Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krane

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Annales De Medecine Interne|December 6, 2000
[Secondary osteoporosis and glucocorticoid-induced osteoporosis]P Orcel, S M Krane
Therapeutics and Clinical Risk Management|May 14, 2008
Use of zoledronic acid in the treatment of Paget's diseaseMargaret Seton, Stephen M Krane
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
Site-directed mutagenesis of type I collagen: effect on susceptibility to collagenaseS M Krane, R Jaenisch
Oncogene|April 18, 1996
NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic miceI M Krane, P Leder
Bone|May 20, 2008
Matrix metalloproteinases and boneStephen M Krane, Masaki Inada
The Journal of Clinical Endocrinology and Metabolism|January 1, 1984
Serum levels of type I and III procollagen fragments in Paget's disease of boneL S Simon, S M Krane, P D Wortman, et al.
European Journal of Rheumatology and Inflammation|January 1, 1990
Clinical implications of cartilage metabolism in arthritisS M Krane, M B Goldring
The Journal of Clinical Investigation|January 1, 1976
Abnormal properties of collagen lysyl hydroxylase from skin fibroblasts of siblings with hydroxylysine-deficient collagenR S Quinn, S M Krane
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 27, 2007
Comparative functional analysis of aquaporins/glyceroporins in mammals and anuransCarissa M Krane, David L Goldstein
Clinical Orthopaedics and Related Research|April 1, 1987
Metabolic consequences of bone turnover in Paget's disease of boneS M Krane, L S Simon
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Annales De Medecine Interne|December 6, 2000
[Secondary osteoporosis and glucocorticoid-induced osteoporosis]P Orcel, S M Krane
Therapeutics and Clinical Risk Management|May 14, 2008
Use of zoledronic acid in the treatment of Paget's diseaseMargaret Seton, Stephen M Krane
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
Site-directed mutagenesis of type I collagen: effect on susceptibility to collagenaseS M Krane, R Jaenisch
Oncogene|April 18, 1996
NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic miceI M Krane, P Leder
Bone|May 20, 2008
Matrix metalloproteinases and boneStephen M Krane, Masaki Inada
The Journal of Clinical Endocrinology and Metabolism|January 1, 1984
Serum levels of type I and III procollagen fragments in Paget's disease of boneL S Simon, S M Krane, P D Wortman, et al.
European Journal of Rheumatology and Inflammation|January 1, 1990
Clinical implications of cartilage metabolism in arthritisS M Krane, M B Goldring
The Journal of Clinical Investigation|January 1, 1976
Abnormal properties of collagen lysyl hydroxylase from skin fibroblasts of siblings with hydroxylysine-deficient collagenR S Quinn, S M Krane
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 27, 2007
Comparative functional analysis of aquaporins/glyceroporins in mammals and anuransCarissa M Krane, David L Goldstein
Clinical Orthopaedics and Related Research|April 1, 1987
Metabolic consequences of bone turnover in Paget's disease of boneS M Krane, L S Simon
Pageof 17